Oberti, F <br/><br/>
Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.  [electronic resource] 

 -  Journal of hepatology  Jan 1997 
 - 167-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0168-8278 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8278(97)80023-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antihypertensive Agents--therapeutic use<br/>Cholestasis--complications<br/>Drug Evaluation, Preclinical<br/>Drug Therapy, Combination<br/>Hemodynamics--drug effects<br/>Hypertension, Portal--etiology<br/>Liver Cirrhosis, Experimental--complications<br/>Male<br/>Multivariate Analysis<br/>Propranolol--therapeutic use<br/>Rats<br/>Rats, Sprague-Dawley<br/>Spironolactone--therapeutic use<br/>Splanchnic Circulation--drug effects<br/>Time Factors